IN DEPTH Regulation starts to catch up with AI in pharma Digital twins: The next frontier to ease clinical trial conduct CMO Moves: Regulatory catalysts for drug manufacturing-January 2023 Outlook CRISPR gene therapies: Is 2023 a milestone year in the making? The first approval decision for a CRISPR gene therapy in 2023 represents a major milestone, setting expectations for things to come 2022 Review Tracking the ups and downs of pharma deals Diversity Embracing trial participants with cognitive impairment Regulation starts to catch up with AI in pharma Digital twins: The next frontier to ease clinical trial conduct CMO Moves: Regulatory catalysts for drug manufacturing-January 01/16/2023 12:03:57
Regulation starts to catch up with AI in pharma
Digital twins: The next frontier to ease clinical trial conduct
CMO Moves: Regulatory catalysts for drug manufacturing-January